BioSpace News Archive

Drug Development

Teva Neuroscience, Inc.: New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis

October 25, 2007
·
1 min read
FDA

Alphatec Holdings, Inc. Receives FDA 510(k) Clearance For the DYNAMO Rod System

October 25, 2007
·
1 min read
Drug Development

Infinity Pharmaceuticals, Inc. and MedImmune, Inc. Present Preliminary Phase 1 Data Demonstrating Biological Activity of IPI-504, A Novel Hsp90 Inhibitor, in Advanced Non-Small Cell Lung Cancer

October 25, 2007
·
1 min read
Business

DARA BioSciences, Inc. Announces New Board Chairman

October 25, 2007
·
4 min read
Policy

Medtronic, Inc. Recall Update: Answers to Frequently Asked Questions From Plaintiffs’ Attorneys Representing Clients in Defective Medtronic Heart Lead Lawsuits

October 25, 2007
·
1 min read
Drug Development

Exelixis, Inc. Interim Phase 2 Data for Exelixis’ XL880 Show Anti-Tumor Activity in Papillary Renal Cell Cancer Tumor Shrinkage Observed in Nearly 80% of Patients

October 25, 2007
·
7 min read
Business

Bruker BioSciences Corporation to Release Third Quarter 2007 Financial Results on October 29, 2007

October 25, 2007
·
1 min read
FDA

KV Pharmaceutical Company Gets FDA OK for Morphine ER 100 mg, 200 mg Tablets

October 25, 2007
·
4 min read
Drug Development

Pharmion Corporation and MethylGene Report Preliminary MGCD0103 Clinical Data at the 2007 AACR-NCI-EORTC International Conference

October 25, 2007
·
7 min read
FDA

QuantRx Biomedical Corporation Announces FDA 510(k) Clearance for Its Follicle Stimulating Hormone (FSH) Immunoassay Test

October 25, 2007
·
1 min read